Cornell Pochily Investment Advisors, Inc. Pfizer Inc Transaction History

Cornell Pochily Investment Advisors, Inc.

$327 Million
Q3 2025

A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 30,203 shares of PFE stock, worth $757,491. This represents 0.24% of its overall portfolio holdings.

Number of Shares

30,203

Previous 29,639 1.9%

Holding current value

$757,491

Previous $718,000 7.1%

% of portfolio

0.24%

Previous 0.24%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$23.29 - $25.88 $13,135 - $14,596	564 Added 1.9%	30,203 $769,000
Q2 2025 Jul 21, 2025	SELL	$21.59 - $24.84 $1,684 - $1,937	-78 Reduced 0.26%	29,639 $718,000
Q1 2025 Apr 17, 2025	SELL	$25.01 - $27.13 $52,996 - $57,488	-2,119 Reduced 6.66%	29,717 $753,000
Q4 2024 Jan 22, 2025	SELL	$24.8 - $30.19 $82,708 - $100,683	-3,335 Reduced 9.48%	31,836 $844,000
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $562,697 - $637,656	20,314 Added 136.73%	35,171 $1.02 Million
Q2 2024 Jul 17, 2024	BUY	$25.26 - $29.6 $39,936 - $46,797	1,581 Added 11.91%	14,857 $415,000
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $2,097 - $2,408	-81 Reduced 0.61%	13,276 $368,000
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $51,711 - $67,167	-1,979 Reduced 12.9%	13,357 $384,000
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $38,411 - $44,899	-1,197 Reduced 7.24%	15,336 $508,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $63,260 - $82,355	-1,606 Reduced 8.85%	16,533 $674,000
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $14,195 - $18,530	-340 Reduced 1.84%	18,139 $929,000
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $62,358 - $76,123	-1,425 Reduced 7.16%	18,479 $809,000
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $14,640 - $18,140	-320 Reduced 1.58%	19,904 $1.03 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $18,387 - $27,256	-445 Reduced 2.15%	20,224 $1.19 Million
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $61,975 - $79,613	1,579 Added 8.27%	20,669 $889,000
Q2 2021 Jul 23, 2021	BUY	$35.91 - $40.68 $64,745 - $73,346	1,803 Added 10.43%	19,090 $748,000
Q1 2021 Apr 22, 2021	BUY	$33.49 - $37.77 $55,258 - $62,320	1,650 Added 10.55%	17,287 $626,000
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $26,842 - $34,133	802 Added 5.41%	15,637 $576,000
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $17,907 - $21,009	564 Added 3.95%	14,835 $544,000
Q2 2020 Jul 24, 2020	BUY	$30.12 - $36.54 $120 - $146	4 Added 0.03%	14,271 $467,000
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $217,996 - $311,470	8,065 Added 130.04%	14,267 $466,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $227,619 - $325,219	-8,421 Reduced 57.59%	6,202 $745,000
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $6,156 - $6,986	-187 Reduced 1.26%	14,623 $573,000
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $131,032 - $169,910	-4,033 Reduced 21.4%	14,810 $532,000
Q2 2019 Jul 22, 2019	BUY	$36.98 - $41.52 $161,787 - $181,650	4,375 Added 30.24%	18,843 $916,000
Q1 2019 Apr 19, 2019	SELL	$37.5 - $41.2 $126,450 - $138,926	-3,372 Reduced 18.9%	14,468 $614,000
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $237,244 - $270,484	6,167 Added 52.83%	17,840 $778,000
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $37,158 - $45,071	-1,078 Reduced 8.45%	11,673 $514,000
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $170,473 - $181,742	-5,169 Reduced 28.84%	12,751 $462,000
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $75,530 - $87,626	2,367 Added 15.22%	17,920 $636,000
Q4 2017 Apr 05, 2018	BUY	$33.26 - $35.29 $517,292 - $548,865	15,553	15,553 $563,000

Others Institutions Holding PFE

# of Institutions

3,353

Shares Held

3.57B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.

Account

Cornell Pochily Investment Advisors, Inc. Pfizer Inc Transaction History